Executive Summary
According to GRD Survey data, the global HPV Testing market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the HPV Testing market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of HPV Testing in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
HPV Testing
Follow-up HPV Testing
Co-testing
Market Snapshot, By Application
Cervical Cancer Screening
Vaginal Cancer Screening
Other
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Seegene, Inc.
Roche Diagnostics
Qiagen
Hologic
BD
Abbott Laboratories
The study objectives of this report are:
To study and analyze the global HPV Testing market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of HPV Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global HPV Testing manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the HPV Testing market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of HPV Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of HPV Testing are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 HPV Testing Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global HPV Testing Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and HPV Testing
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three
4 Market Segment: by Type
4.1 HPV Testing Type Introduction
4.1.1 HPV Testing
4.1.2 Follow-up HPV Testing
4.1.3 Co-testing
4.2 Global HPV Testing Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 HPV Testing Type Introduction
5.1.1 Cervical Cancer Screening
5.1.2 Vaginal Cancer Screening
5.1.3 Other
5.2 Global HPV Testing Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global HPV Testing Market by Region
6.2 North America HPV Testing Market 2016-2021
6.3 Europe HPV Testing Market 2016-2021
6.4 Asia Pacific HPV Testing Market 2016-2021
6.5 South America HPV Testing Market 2016-2021
6.6 Middle East and Africa HPV Testing Market 2016-2021
7 North America
7.1 North America HPV Testing Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe HPV Testing Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific HPV Testing Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America HPV Testing Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa HPV Testing Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
3.1 Seegene, Inc.
3.1.1 Seegene, Inc. Company Information
3.1.2 Seegene, Inc. HPV Testing Product Portfolio, Specification and Application
3.1.3 Seegene, Inc. HPV Testing Revenue and Gross Margin (2019-2021)
3.1.4 Seegene, Inc. Key Development
3.2 Roche Diagnostics
3.2.1 Roche Diagnostics Company Information
3.2.2 Roche Diagnostics HPV Testing Product Portfolio, Specification and Application
3.2.3 Roche Diagnostics HPV Testing Revenue and Gross Margin (2019-2021)
3.2.4 Roche Diagnostics Key Development
3.3 Qiagen
3.3.1 Qiagen Company Information
3.3.2 Qiagen HPV Testing Product Portfolio, Specification and Application
3.3.3 Qiagen HPV Testing Revenue and Gross Margin (2019-2021)
3.3.4 Qiagen Key Development
3.4 Hologic
3.4.1 Hologic Company Information
3.4.2 Hologic HPV Testing Product Portfolio, Specification and Application
3.4.3 Hologic HPV Testing Revenue and Gross Margin (2019-2021)
3.4.4 Hologic Key Development
3.5 BD
3.5.1 BD Company Information
3.5.2 BD HPV Testing Product Portfolio, Specification and Application
3.5.3 BD HPV Testing Revenue and Gross Margin (2019-2021)
3.5.4 BD Key Development
3.6 Abbott Laboratories
3.6.1 Abbott Laboratories Company Information
3.6.2 Abbott Laboratories HPV Testing Product Portfolio, Specification and Application
3.6.3 Abbott Laboratories HPV Testing Revenue and Gross Margin (2019-2021)
3.6.4 Abbott Laboratories Key Development
13 Global HPV Testing Market Forecast by Region by Type and by Application
13.1 Global HPV Testing Revenue Forecast 2022-2027
13.2 Global HPV Testing Forecast by Regions
13.3 Global HPV Testing Forecast by Type
13.4 Global HPV Testing Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global HPV Testing Production Specifications
Table 2: Drivers in HPV Testing Market
Table 3: Restraints HPV Testing Market
Table 4: Opportunity in HPV Testing Market
Table 5: Comparion of Alternative and HPV Testing
Table 6: HPV Testing Raw Materials Key Suppliers List
Table 7: HPV Testing Distributors List
Table 8: HPV Testing Major Buyers in Application One
Table 9: HPV Testing Major Buyers in Application Two
Table 10: HPV Testing Major Buyers in Application Three
Table 11: Global HPV Testing Revenue (Million USD) by Type 2016-2021
Table 12: Global HPV Testing Revenue Market Share by Type 2016-2021
Table 18: Global HPV Testing Revenue (Million USD) by Application 2016-2021
Table 19: Global HPV Testing Revenue Market Share by Application 2016-2021
Table 20: Global HPV Testing Revenue (Million USD) by Region 2016-2021
Table 21: Global HPV Testing Revenue Market Share by Region 2016-2021
Table 22: North America HPV Testing Revenue (Million USD) by Country 2016-2021
Table 23: North America HPV Testing Revenue Market Share by Country 2016-2021)
Table 24: Europe HPV Testing Revenue (Million USD) by Country 2016-2021
Table 25: Europe HPV Testing Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific HPV Testing Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific HPV Testing Revenue Market Share by Country 2016-2021)
Table 28: South America HPV Testing Revenue (Million USD) by Country 2016-2021
Table 29: South America HPV Testing Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa HPV Testing Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa HPV Testing Revenue Market Share by Country 2016-2021)
Table 32 Seegene, Inc. Company Information
Table 33 Seegene, Inc. HPV Testing Product Portfolio, Specification and Application
Table 34 Seegene, Inc. HPV Testing Revenue and Gross Margin (2019-2021)
Table 35 Roche Diagnostics Company Information
Table 36 Roche Diagnostics HPV Testing Product Portfolio, Specification and Application
Table 37 Roche Diagnostics HPV Testing Revenue and Gross Margin (2019-2021)
Table 38 Qiagen Company Information
Table 39 Qiagen HPV Testing Product Portfolio, Specification and Application
Table 40 Qiagen HPV Testing Revenue and Gross Margin (2019-2021)
Table 41 Hologic Company Information
Table 42 Hologic HPV Testing Product Portfolio, Specification and Application
Table 43 Hologic HPV Testing Revenue and Gross Margin (2019-2021)
Table 44 BD Company Information
Table 45 BD HPV Testing Product Portfolio, Specification and Application
Table 46 BD HPV Testing Revenue and Gross Margin (2019-2021)
Table 47 Abbott Laboratories Company Information
Table 48 Abbott Laboratories HPV Testing Product Portfolio, Specification and Application
Table 49 Abbott Laboratories HPV Testing Revenue and Gross Margin (2019-2021)
Table 59: Global HPV Testing Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global HPV Testing Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global HPV Testing Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global HPV Testing Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global HPV Testing Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global HPV Testing Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: HPV Testing Picture
Figure 2: Global HPV Testing Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: HPV Testing Industry Life Cycle
Figure 5: Product Picture of HPV Testing
Figure 6: Product Picture of Follow-up HPV Testing
Figure 9: Global HPV Testing Revenue Market Share by Type, 2020
Reason to Buy